XPH

SPDR S&P Pharmaceuticals ETF · PSE

  • Category Health Care
  • Expense Ratio 0.35%
  • Listing Date Jun 22, 2006
  • Volume 58,357.0
  • Market Cap (AUM) $156.32M

Performance

-2.51%

1W

-4.02%

1M

-3.75%

3M

+10.22%

6M

+5.62%

YTD

+10.56%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Eli Lilly and CompanyLLY5.74%
  • Intra-Cellular Therapies, Inc.ITCI5.49%
  • Elanco Animal Health, Inc.ELAN5.41%
  • Organon & Co.OGN5.41%
  • Merck & Co., Inc.MRK5.08%
  • Axsome Therapeutics, Inc.AXSM5.04%
  • Pfizer Inc.PFE4.94%
  • Catalent IncCTLT4.78%
  • Jazz Pharmaceuticals Public Limited CompanyJAZZ4.70%
  • Zoetis, Inc. Class AZTS4.57%

Technical Analysis of XPH 2024-12-20

The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 23 indicating strong bearish momentum, the Oscillators Score at 46 suggesting a neutral stance, and the Technical Score at 35 reinforcing the bearish outlook. This combination signals caution for potential investors, as the prevailing trend leans towards w...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.